Viewing Study NCT04572620


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT04572620
Status: UNKNOWN
Last Update Posted: 2020-10-01
First Post: 2020-09-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module